Drug Database · Clinicians

Carboxymethylcellulose + Glycerin

Also known as: carmellose (international nonproprietary name and British name, for carboxymethylcellulose)

Brands (1) NeotearShow all

US brand (reference label): VitaPhyte Lubricant Eye Drops; not a Philippine-registered brand.

Non-Standardized Chemical Allergen US FDA class
Lubricant PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 5d39f7b1-c0ed-33dc-e063-6394a90aee31, version date October 7, 2026 (VitaPhyte Lubricant Eye Drops · Guangzhou Liyan Cosmetics Technology Co., Ltd.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • For the temporary relief of burning and irritation due to dryness of the eye.
  • For use as a protectant against further irritation or to relieve dryness of the eye.
US FDA label
Full indications and usage US FDA label

Uses • For the temporary relief of burning and irritation due to dryness of the eye. • For use as a protectant against further irritation or to relieve dryness of the eye.

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions • Instill1 or 2 drops in the affected eye(s) as needed.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Ophthalmic solution: 5 mg/mL (0.5 %)/9 mg/mL

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Carboxymethylcellulose + Glycerin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Carboxymethylcellulose + Glycerin
Package insert
NeotearCarboxymethylcellulose Sodium + Glycerin
5mg/mL (0.5%)/ 9mg/mL (0.9%) Ophthalmic Solution (Eye Drops)10mL White Opaque LDPE Bottle (Box of 1's)
Rx
Aristopharma Ltd.Bangladesh
Sahar International Trading Inc.
DRP-7045
Jan 11, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Warnings For external use only Do not use ● if solution changes color or becomes cloudy. When using this product ● to avoid contamination, do not touch tip of container to any surface. Replace cap after using. Stop use and ask a doctor if ● you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. VitaPhyte Lubricant Eye Drops · Guangzhou Liyan Cosmetics Technology Co., Ltd. [US FDA-approved label, version 2, October 7, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d39f7b1-c0ed-33dc-e063-6394a90aee31
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .